Cargando…

Blood test shows high accuracy in detecting stage I non-small cell lung cancer

BACKGROUND: In a previous study (Goebel et. al, Cancer Genomics Proteomics 16:229-244, 2019), we identified 33 biomarkers for an early stage (I-II) Non-Small Cell Lung Cancer (NSCLC) test with 90% accuracy, 80.3% sensitivity, and 95.4% specificity. For the current study, we used a narrowed ensemble...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goebel, Cherylle, Louden, Christopher L., Mckenna, Robert, Onugha, Osita, Wachtel, Andrew, Long, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035746/ https://www.ncbi.nlm.nih.gov/pubmed/32085733 http://dx.doi.org/10.1186/s12885-020-6625-x

Ejemplares similares

The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data
por: Navani, Neal, et al.
Publicado: (2019)

Yellow-Gold Polarized Light Microscopy May Improve Accuracy of Pathological Staging of Colorectal Adenocarcinoma
por: Puckett, Yana, et al.
Publicado: (2020)

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients
por: Qi, Jing, et al.
Publicado: (2021)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Arterial blood gases predict long-term prognosis in stage I non-small cell lung cancer patients
por: Mizuguchi, Shinjiro, et al.
Publicado: (2016)

Effect of body mass index on survival of patients with stage I non-small cell lung cancer
por: Xie, Hao-Jun, et al.
Publicado: (2017)

Accuracy of lung cancer staging in the multidisciplinary team setting
por: Liam, Chong-Kin, et al.
Publicado: (2020)

Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery
por: Doerr, Fabian, et al.
Publicado: (2022)

Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey
por: Lammers, Austin, et al.
Publicado: (2018)

Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
por: Hockmann, Jan, et al.
Publicado: (2023)

Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer
por: Ma, Jun, et al.
Publicado: (2017)

Integrated models of blood protein and metabolite enhance the diagnostic accuracy for Non-Small Cell Lung Cancer
por: Xu, Runhao, et al.
Publicado: (2023)

Optimal sequence of tests for the mediastinal staging of non-small cell lung cancer
por: Luque, Manuel, et al.
Publicado: (2016)

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases
por: Fritz, Peter, et al.
Publicado: (2006)

The evaluation of accuracy of serial rapid HIV test algorithm in the diagnosis of HIV antibodies among pregnant women in south east Nigeria
por: Mbachu, Ikechukwu Innocent, et al.
Publicado: (2015)

Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer
por: Jiang, Wei, et al.
Publicado: (2015)

Wedge Resection and Segmentectomy in Patients with Stage I Non-Small Cell Lung Carcinoma
por: Reveliotis, Konstantinos, et al.
Publicado: (2014)

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

Serum lipidome screening in patients with stage I non-small cell lung cancer
por: Klupczynska, Agnieszka, et al.
Publicado: (2019)

Surgery for limited stage small cell lung cancer
por: Gergen, Anna K., et al.
Publicado: (2020)

Percutaneous Cryoablation for the Treatment of Medically Inoperable Stage I Non-Small Cell Lung Cancer
por: Yamauchi, Yoshikane, et al.
Publicado: (2012)

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
por: KIM, MIN-JEONG, et al.
Publicado: (2013)

Recurrence Risk Factors Analysis for Stage I Non-small CellLung Cancer: Erratum
Publicado: (2015)

Moderately Hypofractionated Radiotherapy Alone for Stage I-IIB Non-small Cell Lung Cancer
por: Hughes, Ryan T, et al.
Publicado: (2019)

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Cho, Su Han, et al.
Publicado: (2021)

Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer
por: Tsutani, Yasuhiro, et al.
Publicado: (2021)

Machine learning approaches to predicting no-shows in pediatric medical appointment
por: Liu, Dianbo, et al.
Publicado: (2022)

Diagnostic Accuracy of Capillary Blood Glucometer Testing for Gestational Diabetes
por: Gallardo-Rincón, Héctor, et al.
Publicado: (2022)

Peripheral blood lymphocytes of critically ill patients show signs of late stage apoptosis
por: Weber, SU, et al.
Publicado: (2003)

Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer
por: Sun, Yu-Qin, et al.
Publicado: (2017)

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer
por: Kubo, Hiroshi, et al.
Publicado: (2014)

Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Small Academic Hospital Experience
por: Factor, Oren B., et al.
Publicado: (2014)

Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer
por: Jin, Ying, et al.
Publicado: (2013)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
por: Takahashi, Wataru, et al.
Publicado: (2014)

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients
por: Liu, Chia-Hsin, et al.
Publicado: (2015)

Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer
por: Wang, Xin, et al.
Publicado: (2019)

Racial Disparities in Time From Diagnosis to Treatment for Stage I Non–Small Cell Lung Cancer
por: Holmes, Jordan A, et al.
Publicado: (2018)

Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2020)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_87ocjk1r9mpla1q8nfdiobtb8o